VK

Vibhuanand Kumar Pandey

Active Director Director DIN 11743234
DIN 11743234 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Vibhuanand Kumar Pandey

Data last updated:

Vibhuanand Kumar Pandey is a Director at U R Pharma Medicine Private Limited (since 2026) and Director at U R Pharmaceticals Private Limited (since 2026).

DIN 11743234
Primary Designation Director
First Appointment 26 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
U R Pharma Medicine Private Limited U46497BR2026PTC087564
Director23 Aug 20262026Active
U R Pharmaceticals Private Limited U46497BR2026PTC085302
Director26 May 20262026Active

Board colleagues of Vibhuanand Kumar Pandey

Directorship timeline

Open interactive timeline →
U R Pharmaceticals Private Limited
U R Pharma Medicine Private Limited
Premium access

Shareholding and investment profile for Vibhuanand Kumar Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vibhuanand Kumar Pandey

Vibhuanand Kumar Pandey currently holds 2 directorships: U R Pharma Medicine Private Limited (Director, since 23 Aug 2026); U R Pharmaceticals Private Limited (Director, since 26 May 2026).

Vibhuanand Kumar Pandey was first appointed on 26 May 2026 as Director at U R Pharmaceticals Private Limited.

The current boards of Vibhuanand Kumar Pandey's companies include Arti Kumari (U R Pharma Medicine Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available